Norwegian Cruise Line (NYSE:NCLH – Free Report) had its target price hoisted by Macquarie from $24.00 to $30.00 in a report published on Friday morning, Benzinga reports. The brokerage currently has an outperform rating on the stock.
Other research analysts also recently issued research reports about the company. Truist Financial increased their price target on Norwegian Cruise Line from $21.00 to $25.00 and gave the company a “buy” rating in a research note on Thursday, September 26th. StockNews.com cut Norwegian Cruise Line from a “hold” rating to a “sell” rating in a report on Wednesday, October 30th. Morgan Stanley lifted their price target on Norwegian Cruise Line from $17.50 to $19.00 and gave the stock an “underweight” rating in a report on Wednesday, October 30th. Tigress Financial reiterated a “strong-buy” rating and set a $32.00 price target on shares of Norwegian Cruise Line in a report on Friday, August 9th. Finally, Citigroup upgraded shares of Norwegian Cruise Line from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $20.00 to $30.00 in a research report on Wednesday, October 9th. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating, six have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, Norwegian Cruise Line currently has an average rating of “Hold” and an average target price of $25.80.
Read Our Latest Report on NCLH
Norwegian Cruise Line Trading Up 1.1 %
Norwegian Cruise Line (NYSE:NCLH – Get Free Report) last released its quarterly earnings results on Thursday, October 31st. The company reported $0.99 EPS for the quarter, topping analysts’ consensus estimates of $0.94 by $0.05. The business had revenue of $2.81 billion for the quarter, compared to analyst estimates of $2.77 billion. Norwegian Cruise Line had a return on equity of 99.31% and a net margin of 5.87%. Norwegian Cruise Line’s revenue for the quarter was up 10.7% on a year-over-year basis. During the same period in the prior year, the company earned $0.71 EPS. Equities analysts anticipate that Norwegian Cruise Line will post 1.65 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently bought and sold shares of NCLH. Transcendent Capital Group LLC bought a new stake in shares of Norwegian Cruise Line during the 1st quarter valued at about $27,000. Sentry Investment Management LLC bought a new position in Norwegian Cruise Line in the 2nd quarter worth about $39,000. Blue Trust Inc. boosted its position in shares of Norwegian Cruise Line by 489.8% during the third quarter. Blue Trust Inc. now owns 2,188 shares of the company’s stock worth $41,000 after buying an additional 1,817 shares during the period. Fidelis Capital Partners LLC bought a new position in Norwegian Cruise Line in the 1st quarter worth approximately $61,000. Finally, Moisand Fitzgerald Tamayo LLC bought a new stake in Norwegian Cruise Line during the 3rd quarter valued at $78,000. Hedge funds and other institutional investors own 69.58% of the company’s stock.
Norwegian Cruise Line Company Profile
Norwegian Cruise Line Holdings Ltd., together with its subsidiaries, operates as a cruise company in North America, Europe, the Asia-Pacific, and internationally. The company operates through the Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises brands. It offers itineraries ranging from three days to a 180-days calling on various ports, including Scandinavia, Northern Europe, the Mediterranean, the Greek Isles, Alaska, Canada and New England, Hawaii, Asia, Tahiti and the South Pacific, Australia and New Zealand, Africa, India, South America, the Panama Canal, and the Caribbean.
Featured Articles
- Five stocks we like better than Norwegian Cruise Line
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Intel: Is Now the Time to Be Brave?Â
- P/E Ratio Calculation: How to Assess Stocks
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- There Are Different Types of Stock To Invest In
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Norwegian Cruise Line Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Norwegian Cruise Line and related companies with MarketBeat.com's FREE daily email newsletter.